Search results
Results From The WOW.Com Content Network
Ritesh Agarwal (born 16 November 1993) is an Indian billionaire entrepreneur [2] and the founder and CEO of OYO Rooms, a hospitality chain. [3] He has been a panellist on Shark Tank India (season 3) in 2024. [4] Agarwal listed among Top 10 youngest Indian billionaires in Hurun Rich List of India 2024, with a net worth of $225 million (₹ 1,900 ...
This is the list of Schedule III controlled substances in the United States as defined in section 202 of the Controlled Substances Act (21 U.S.C. § 812) and 21 CFR 1308.13. The following findings are required for substances to be placed in this schedule:
Examples of these substances are phosgene, which has been used as a chemical weapon but which is also a precursor in the manufacture of many legitimate organic compounds, and triethanolamine, used in the manufacture of nitrogen mustard but also commonly used in toiletries and detergents. The Schedule 3 list is one of three lists.
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Donate; Help; Learn to edit; Community portal; Recent changes; Upload file
Class 3: Flammable Liquids A flammable liquid is a liquid having a flash point of not more than 60 °C (140 °F), or any material in a liquid phase with a flash point at or above 37.8 °C (100 °F) that is intentionally heated and offered for transportation or transported at or above its flash point in a bulk packaging.
IARC group 3 substances, ... The IARC Monographs on which this list is based assess the hazard linked to the agents, they do not assess the cancer risk of the agents. [1]
In 2012, Ritesh Agarwal launched Oravel Stays as a budget accommodation listing and booking website, later renamed to OYO in 2013. [11] Shortly after launching Oravel Stays, Ritesh Agarwal received a grant of $100,000 as part of the Thiel Fellowship, a two-year program from PayPal co-founder Peter Thiel. [12] [13]
Namita Thapar (née Mehta; born 21 March 1977) is an Indian entrepreneur, business executive, and angel investor. [1] She is the Executive director of Emcure Pharmaceuticals. [2]